No Data
No Data
EnGene Holdings(ENGN.US) 10% Shareholder Sells US$787.98K in Common Stock
$enGene Holdings(ENGN.US)$ 10% Shareholder FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC sold 52,529 shares of common stock on Apr 18, 19, 22, 2024 at an average price of $15 for a total value of $78
Buy Rating Justified for EnGene Holdings Amidst Strong EG-70 Prospects and Competitive Edge
EnGene to Present Details of Its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer With Carcinoma in Situ at the American Urology Association 2024 Annual Meeting
Oral presentation highlights rational design of EG-70 to address challenges faced by other intravesical treatment options, including preparation, handling, and safety considerations BOSTON and MONTRE
EnGene Holdings Initiated at Overweight by Wells Fargo
EnGene Holdings Initiated at Overweight by Wells Fargo
EnGene Holdings (ENGN.US) was first covered by Wells Fargo, giving it an increase rating, with a target price of $30.00.
EnGene Holdings (ENGN.US) was first covered by Wells Fargo, giving it an increase rating, with a target price of $30.00.
Wells Fargo Initiates Coverage On EnGene Holdings With Overweight Rating, Announces Price Target of $30
Wells Fargo analyst Yanan Zhu initiates coverage on enGene Holdings with a Overweight rating and announces Price Target of $30.
No Data